LGALS3 and obstructive sleep apnea syndrome: Considering that galectin-3 is linked to the severity of OSA and plays a crucial role in inflammation induced by intermittent hypoxia in OSA, further screening and interventions targeting galectin-3 could aid in preventing inflammatory diseases related to sleep disturbances.